Close Menu

Framingham Heart Study

The long-running Framingham Heart Study has received a $38 million grant, according to the Boston Globe.

By combining genome-wide association and mRNA expression data, a National Heart, Lung, and Blood Institute-led team uncovered gene networks involved in blood pressure regulation.

An analysis in the Proceedings of the National Academy of Sciences suggests the association between obesity and an FTO gene variant became increasingly significant in the past several decades.

NEW YORK (GenomeWeb News) – Two studies appearing in the American Journal of Human Genetics today uncovered a handful of low-frequency variants, including novel variants in ANGPTL8, PNPLA5, and PCSK7, among others, that seem to contribute to cholesterol or lipid levels in the blood.

This story has been updated to correct a quote citing a BG official saying BNP is a marker of inflammation. In fact, he said that it was a marker of "loading and stretch."

The university will conduct studies of factors in predicting atrial fibrillation by using date from the Framingham Heart Study.

The collaboration is the first cooperative research-and-development agreement between FHS and a commercial partner in the study's 60-year history. It also marks the first time the study has ever used proteomics.

The collaboration with BG marks the first time the Framingham Heart Study has partnered with a commercial company on a CRADA project.

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.